Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days. [electronic resource]
- Influenza and other respiratory viruses Sep 2013
- 833-7 p. digital
Publication Type: Journal Article; Observational Study
1750-2659
10.1111/irv.12065 doi
Adult Antiviral Agents--therapeutic use Female Humans Influenza A Virus, H1N1 Subtype--drug effects Influenza, Human--drug therapy Male Middle Aged Oseltamivir--therapeutic use Pandemics Prospective Studies Republic of Korea--epidemiology Virus Shedding--drug effects Young Adult